https://www.pharmaceutical-technology.com/analyst-comment/gilead-immunomedics-aquisition/
Gilead has announced the acquisition of the biopharmaceutical company Immunomedics for $21B, as the pharma giant looks to bolster its cancer portfolio.
gileadannouncesaquisitionimmunomedicsboost
https://www.fiercebiotech.com/biotech/immunomedics-nabs-j-j-veteran-for-cmo-as-it-presses-adc-redo
For the last year, biopharma veteran Loretta Itri, M.D. has been helping Immunomedics out with its troubled antibody-drug conjugate, sacituzumab govitecan.
immunomedicsnabsjveterancmo
https://www.fool.com/investing/2020/05/12/why-immunomedics-stock-skyrocketed-125-in-april.aspx
This biotech's advanced breast cancer drug got the green light from the FDA.
motley foolimmunomedicsstockapril